DiGeorge Syndrome :: Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome

More than 20 years ago, doctors at Mattel Children’s Hospital UCLA performed a successful bone marrow transplant on a baby girl who was born without a thymus gland and was suffering from severe immune deficiency. It marked the first time a bone marrow transplant, rather than a thymic transplant, had been used to treat the genetic condition known as DiGeorge Syndrome (DGS).

Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS).

Breast Cancer :: Women who bear children have a reduced risk of developing breast cancer

The benefits of motherhood: Fetal Cell “Transplant” could be a hidden link between childbirth and reduced risk of breast cancer. Some benefits of motherhood are intangible, but one has been validated through biostatistical research: women who bear children have a reduced risk of developing breast cancer.